DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fidarestat
Fidarestat
WHO Drug Information Vol. 12, No. 3, 1998
IP Vol.2 No.2 Jul-Dec 2014.Pmd
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Aldose Reductase Inhibitors for Diabetic Cataract: a Study of Disclosure Patterns in Patents and Peer Review Papers
A Role for the Polyol Pathway in the Early Neuroretinal Apoptosis And
Aldose Reductase
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
(12) United States Patent (10) Patent No.: US 7.416,744 B2 Rubin Et Al
Evaluation of the Aldose Reductase Inhibitor Fidarestat on Ischemia-Reperfusion Injury in Rat Retina
Stembook 2018.Pdf
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
(12) United States Patent (10) Patent No.: US 8,846,695 B2 Dugi (45) Date of Patent: Sep
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
Berrchem Company Ltd API List
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Aldose Reductase Inhibitor Fidarestat Counteracts Diabetes-Associated Cataract Formation, Retinal Oxidative- Nitrosative Stress, Glial Activation, and Apoptosis
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Top View
(12) United States Patent (10) Patent No.: US 9,526,728 B2 Klein Et Al
Pharmacology – Diabetes Drugs
Aldose Reductase Inhibitors As Potential Therapeutic Drugs of Diabetic Complications
Diabetic Neuropathy: Cellular Mechanisms As Therapeutic Targets Andrea M
Pharmaabkommen A1 E
Pharmacological Modulation of Long Cardiac QT Interval in Ex Vivo and in Vitro Experimental Models
Customs Tariff - Schedule Xxi - 1
Bioactive Compound Library Plus (96-Well)
Diabetic Neuropathy
(12) Patent Application Publication (10) Pub. No.: US 2016/0082123 A1 RAU Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
List of Ninety Seven Anti-Diabetic Drugs
シンポジウム1:肥満の成因と治療 Symposium1:Causes and Treatment of Obesity 座長 中里 雅光 下村伊一郎 !Chairs Masamitsu Nakazato Iichiro Shimomura
WO 2U11/132171 Al
Pharmaceutical Appendix to the Tariff Schedule 2
(12) Patent Application Publication (10) Pub. No.: US 2014/0296257 A1 Hersel Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Review Article Diabetic Neuropathy and Oxidative Stress: Therapeutic Perspectives
Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-Diabetic Diseases
Stop Crying Over Spilled Milk, Thanks to Recent Reports Which Suggest
Mitogen-Activated Protein Kinase P38 Mediates Reduced Nerve Conduction Velocity in Experimental Diabetic Neuropathy Interactions with Aldose Reductase Sally A
Jpp Journal of Proteins and Proteomics
WO 2011/012715 Al
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications Irina G